PMV Pharmaceuticals, Inc. (PMVP)
NASDAQ: PMVP · Real-Time Price · USD
1.630
-0.010 (-0.61%)
At close: Mar 9, 2026, 4:00 PM EDT
1.622
-0.008 (-0.51%)
After-hours: Mar 9, 2026, 6:56 PM EDT

PMV Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2018
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2018
Net Income
-77.74-58.71-68.96-73.32-57.85
Upgrade
Depreciation & Amortization
0.131.141.260.320.31
Upgrade
Loss (Gain) From Sale of Assets
0.040.06---
Upgrade
Loss (Gain) From Sale of Investments
-2.77-5.37-5.39-0.630.55
Upgrade
Stock-Based Compensation
5.928.8712.3810.25.34
Upgrade
Other Operating Activities
-0.074.31-0.370.240.96
Upgrade
Change in Accounts Payable
-3.423.340.24-0.390.19
Upgrade
Change in Other Net Operating Assets
4.34-4.935.19-0.183.93
Upgrade
Operating Cash Flow
-73.58-51.28-55.66-63.76-46.57
Upgrade
Capital Expenditures
-0.03-0.66-0.96-7.98-1.35
Upgrade
Sale of Property, Plant & Equipment
0.030.25---
Upgrade
Investment in Securities
70.1753.76-49.586.62-142.24
Upgrade
Investing Cash Flow
70.1753.35-50.55-1.37-143.58
Upgrade
Issuance of Common Stock
0.510.3135.580.962.02
Upgrade
Financing Cash Flow
0.510.3135.580.962.02
Upgrade
Foreign Exchange Rate Adjustments
0.01-0.040.03--
Upgrade
Net Cash Flow
-2.892.35-70.59-64.17-188.13
Upgrade
Free Cash Flow
-73.61-51.94-56.62-71.74-47.92
Upgrade
Free Cash Flow Per Share
-1.40-1.01-1.18-1.57-1.06
Upgrade
Cash Income Tax Paid
----0.02
Upgrade
Levered Free Cash Flow
-48.9-44.68-32.94-48.97-27.51
Upgrade
Unlevered Free Cash Flow
-52.86-44.68-32.94-48.97-27.51
Upgrade
Change in Working Capital
0.91-1.595.43-0.574.12
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.